ZNF343: A Potential Drug Target and Biomarker for Various Diseases
ZNF343: A Potential Drug Target and Biomarker for Various Diseases
ZNF343 (MGC10715) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZNF343 is a non-coding RNA molecule that is expressed in various tissues and cell types in the body.
The ZNF343 gene is part of the Zinc Finger Nucleotide (ZNF) gene family, which is known for its role in regulating gene expression and cell development. ZNF343 is a splicing variant of the ZNF3 gene, which is located on chromosome 16p13.3.
ZNF343 has been shown to play a role in various cellular processes, including cell growth, differentiation, and apoptosis (programmed cell death). It is also involved in the regulation of gene expression and has been associated with the development and progression of various diseases.
One of the most promising aspects of ZNF343 is its potential as a drug target. The ZNF343 gene has been shown to be highly expressed in various tissues and cell types, including cancer cells, and has been associated with the development of various types of cancer.
In addition, ZNF343 has also been shown to be involved in the regulation of cellular processes that are important for cancer progression, such as the angiogenic process. The angiogenic process is the process by which cancer cells develop blood vessels to supply themselves with oxygen and nutrients, which is a critical step in the development of cancer.
Another promising aspect of ZNF343 is its potential as a biomarker. The ZNF343 gene has been shown to be expressed in various tissues and cell types, including cancer cells, and has been associated with the development and progression of various diseases.
For example, ZNF343 has been shown to be highly expressed in breast cancer cells and has been associated with the development of various types of breast cancer. It is also involved in the regulation of cellular processes that are important for the growth and survival of cancer cells , which may make it an attractive target for cancer therapies.
In addition, ZNF343 has also been shown to be involved in the regulation of cellular processes that are important for neurodegenerative diseases, such as Alzheimer's disease. The neurodegenerative diseases are a group of conditions that are characterized by the progressive loss of brain cells and are often associated with aging.
ZNF343 has been shown to be involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases, such as the aggregation of beta-amyloid peptides, which are a hallmark of Alzheimer's disease. The aggregation of beta-amyloid peptides is thought to play a role in the destruction of nerve cells in the brain, which is characteristic of neurodegenerative diseases.
In addition, ZNF343 has also been shown to be involved in the regulation of cellular processes that are important for autoimmune disorders. The autoimmune disorders are a group of conditions in which the immune system attacks the body's own tissues, leading to a range of symptoms and conditions.
ZNF343 has been shown to be involved in the regulation of cellular processes that are important for the development and progression of autoimmune disorders, such as the regulation of T cells, which are a key part of the immune system. T cells are responsible for helping the The body fights off infections and diseases, and are often involved in autoimmune disorders.
In conclusion, ZNF343 is a gene that has been identified as a potential drug target and biomarker for various diseases. Its involvement in cellular processes that are important for cancer, neurodegenerative diseases, and autoimmune disorders makes it an attractive target for
Protein Name: Zinc Finger Protein 343
Functions: May be involved in transcriptional regulation
The "ZNF343 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF343 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500
